首页
期刊中心
期刊检索
论文检索
行业资讯
期刊
期刊
论文
首页
>
《癌症生物学与医学:英文版》
>
2017年4期
>
Promoter methylation of Wnt/β-Catenin signal inhibitor TMEM88 is associated with unfavorable prognosis of non- small cell lung cancer
Promoter methylation of Wnt/β-Catenin signal inhibitor TMEM88 is associated with unfavorable prognosis of non- small cell lung cancer
打印
分享
在线阅读
下载PDF
导出详情
摘要
未填写
DOI
rdx5z7o9jl/1801897
作者
Rongna Ma;Nannan Feng;Xiao Yu;Hongyan Lin;Xiaohong Zhang;Oumin Shi;Huan Zhang;Shuo Zhang;Lei Li;Min Zheng;Ming Gao;Herbert Yu;Biyun Qian
机构地区
不详
出处
《癌症生物学与医学:英文版》
2017年4期
关键词
分类
[医药卫生][肿瘤]
出版日期
2017年04月14日(中国期刊网平台首次上网日期,不代表论文的发表时间)
相关文献
1
林东;王恩华;张志坤;徐洪涛;李庆昌;邱雪杉.
EXPRESSION OF PHOSPHO-b-CATENIN AND ITS SIGNIFICANCE IN NON-SMALL CELL LUNG CANCER
.肿瘤,2003-01.
2
LianChen;RuiChen;ZheZhu;YichenZhang;ZhengweiWen;YunLi;XiaomingLi;YuwenLuo;LiyuMa;ShuguangLin;XinChen.
Predictive factors associated with gefitinib response in patients with advanced non-small-cell lung cancer (NSCLC)
.肿瘤,2014-04.
3
Zhou Fei,Zhou Cai-Cun.
Immunotherapy in non-small cell lung cancer: advancements and challenges
.医药卫生,2021-05.
4
Alexandra Giatromanolaki;Konstantina Balaska;Dimitra Kalamida;Christos Kakouratos;Efthimios Sivridis;Michael I. Koukourakis.
Thermogenic protein UCP1 and UCP3 expression in non- small cell lung cancer: relation with glycolysis and anaerobic metabolism
.肿瘤,2017-04.
5
Li Chu-Ling,Song Yong.
Combination strategies of immunotherapy in non-small cell lung cancer: facts and challenges
.医药卫生,2021-09.
6
Yu-Sook Jeong;Hye-Suk Han;Sung-Nam Lim;Mi-Jin Kim;Joung-Ho Han;Min-Ho Kang;Dong-Hee Ryu;Ok-Jun Lee;Ki-Hyeong Lee;Seung-Taik Kim.
Gallbladder Metastasis of Non-small Cell Lung Cancer Presenting as Acute Cholecystitis
.肿瘤,2012-03.
7
单根法;钟竑;张辅贤;李国庆;隆桂麟;顾鹤定;戚晓敏.
Expression and Prognostic Significance of Multidrug Resistance Associated Protein (MRP) Gene in Non-small Cell Lung Cancer by in Site Hybridization
.肿瘤,2000-03.
8
Siyuan Ren,Mengyao Ma,Chuan He,Yuhui Deng,Xiaoyun Chen,Yonglin Liu,Yangyang Jin,Yansong Liu,Lei Cai,Lin He.
Placebo effect in the treatment of non-small cell lung cancer: a meta-analysis
.医药卫生,2022-12.
9
Fajiu Li,Ying Chen,Juanjuan Wu,Chenghong Li,Shi Chen,Ziyang Zhu,Wei Qin,Min Liu,Bingzhu Hu,Shuang Liu,Wenzhao Zhong.
The earlier, the better? A review of neoadjuvant immunotherapy in resectable non-small-cell lung cancer
.医药卫生,2022-12.
10
CAO,Zhengyi.
Postoperative Radiotherapy and N2 Non-small Cell Lung Cancer Prognosis:A Retrospective Study Based on Surveillance,Epidemiology,and End Results Database
.,2023-03.
来源期刊
癌症生物学与医学:英文版
2017年4期
相关推荐
FDA expands approval of Imfinzi to reduce the risk of non-small cell lung cancer progressing
ADJUVANT CHEMOTHERAPY FOLLOWING RADICAL SURGERYFOR NON-SMALL CELL LUNG CANCER:A RANDOMIZED STUDY
Treating non-small cell lung cancer by targeting the PI3K signaling pathway
Inhibitory Effects of Natural Compound Alantolactone on Human Non-small Cell Lung Cancer A549 Cells
Analysis of factors influencing skip lymphatic metastasis in pN2 non-small cell lung cancer
同分类资源
更多
[肿瘤]
基于“精准宣教”的个性化快速康复外科配合家庭“O2O”宣教模式在老年结直肠癌患者围手术期的应用
[肿瘤]
内侧型蝶骨嵴脑膜瘤显微神经外科手术中血管和神经的保护
[肿瘤]
锻炼可提高癌症病人的免疫功能
[肿瘤]
INTERACTION OF COMPONENT (E) WITH TUMOR CELLULAR DNA
[肿瘤]
3D腹腔镜与2D腹腔镜在乙状结肠癌根治术中应用的近期疗效对比分析
相关关键词
返回顶部